Studies

CellWell record HH-227073

Prior Authorization and Associated Delays and Denials of Branded Medication Dispensation

Yang Wang; J. F. Levy; T. Mattingly; Gerard F. Anderson

JAMA Health Forum ยท 2026

In plain language

Prior authorization for branded medications resulted in treatment delays for 65% of prescriptions and eventual denials for 46%, with claim complexity and patient characteristics associated with lower approval rates.

Evidence
Emerging
Design
Primary research (design unspecified)

Read it on DOI

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-227073

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.